RxDoctor Payments Data

Michael Hoa, MD

Otolaryngology · Washington, DCNPI 1194932921

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by GSK at 43.6% of the total. Reporting peaked in 2024 at $31,122 and has fallen 73.8% since, to $8,157 in 2025. Among otolaryngology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,317in general payments, 2019–2025

Across 133 payments — averaging $430.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$25K
  • Med-el Corporation$9K
  • Cook Medical LLC$8K
  • Cochlear Americas$6K
  • Cook Incorporated$2K
  • Eli Lilly$2K
  • plus $5K from 18 others
$45,116in research payments, 2019–2025

Across 9 payments — averaging $5012.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$45K

What the payments were for

  • Consulting fees$14,06525%
  • Speaking & faculty fees$31,02554%
  • Travel & lodging$5,52110%
  • Food & beverage$6,70712%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,317 in reported general payments places this provider in the 95th percentile of 41 otolaryngology providers in District of Columbia.

See all otolaryngology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$62,267
Medicare patients
148
Services billed
448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →